Reducing Risk of Type 2 Diabetes Mellitus with Alendronate - A Promising Possibility for the Indian Population

Indian J Pharmacol. 2022 Jan-Feb;54(1):65-66. doi: 10.4103/ijp.ijp_828_21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alendronate / therapeutic use
  • Case-Control Studies
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Osteoporosis*

Substances

  • Alendronate